By: Maribel Yoo On: June 13, 2019 In: Nexus Strategy, Portfolio Comments: 0
Perfuse Logo

Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion with a novel mechanism in the context of several retinal diseases including glaucoma, non-proliferative diabetic retinopathy and intermediate age-related macular degeneration.  The company was founded by OrbiMed Advisors and is supported by a syndicate of investors including Hatteras Ventures, Lily Ventures, and Wu Capital.

Deal Source

Dr. Justin Hanes

Board Representation

George Petrocheilos